Related references
Note: Only part of the references are listed.ShinyGO: a graphical gene-set enrichment tool for animals and plants
Steven Xijin Ge et al.
BIOINFORMATICS (2020)
The Hippo Pathway: Biology and Pathophysiology
Shenghong Ma et al.
ANNUAL REVIEW OF BIOCHEMISTRY, VOL 88 (2019)
YAPping about and not forgetting TAZ
Bernard A. Callus et al.
FEBS LETTERS (2019)
The Hippo pathway effector proteins YAP and TAZ have both distinct and overlapping functions in the cell
Steven W. Plouffe et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2018)
ETS (E26 transformation-specific) up-regulation of the transcriptional co-activator TAZ promotes cell migration and metastasis in prostate cancer
Chen-Ying Liu et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2017)
Loss of YAP1 defines neuroendocrine differentiation of lung tumors
Takeshi Ito et al.
CANCER SCIENCE (2016)
YAP and TAZ modulate cell phenotype in a subset of small cell lung cancer
Masafumi Horie et al.
CANCER SCIENCE (2016)
Divergent clonal evolution of castration-resistant neuroendocrine prostate cancer
Himisha Beltran et al.
NATURE MEDICINE (2016)
Clinicopathological significance of p15 promoter hypermethylation in multiple myeloma: a meta-analysis
Bing Wei et al.
ONCOTARGETS AND THERAPY (2016)
Hippo Pathway in Organ Size Control, Tissue Homeostasis, and Cancer
Fa-Xing Yu et al.
CELL (2015)
The Hippo Pathway Effector YAP Regulates Motility, Invasion, and Castration-Resistant Growth of Prostate Cancer Cells
Lin Zhang et al.
MOLECULAR AND CELLULAR BIOLOGY (2015)
YAP1 and AR interactions contribute to the switch from androgen-dependent to castration-resistant growth in prostate cancer
Gamze Kuser-Abali et al.
NATURE COMMUNICATIONS (2015)
Prognostic Value of Yes-Associated Protein 1 (YAP1) in Various Cancers: A Meta-Analysis
Zhenqiang Sun et al.
PLOS ONE (2015)
YAP/TAZ Incorporation in the β-Catenin Destruction Complex Orchestrates the Wnt Response
Luca Azzolin et al.
CELL (2014)
Aggressive Variants of Castration-Resistant Prostate Cancer
Himisha Beltran et al.
CLINICAL CANCER RESEARCH (2014)
Restriction of intestinal stem cell expansion and the regenerative response by YAP
Evan R. Barry et al.
NATURE (2013)
A molecular mechanism that links Hippo signalling to the inhibition of Wnt/β-catenin signalling
Masamichi Imajo et al.
EMBO JOURNAL (2012)
The Cancer Cell Line Encyclopedia enables predictive modelling of anticancer drug sensitivity
Jordi Barretina et al.
NATURE (2012)
miR-375 Is Activated by ASH1 and Inhibits YAP1 in a Lineage-Dependent Manner in Lung Cancer
Eri Nishikawa et al.
CANCER RESEARCH (2011)
Wnt/β-Catenin activation promotes prostate tumor progression in a mouse model
X. Yu et al.
ONCOGENE (2011)
The Hippo Pathway Regulates Wnt/β-Catenin Signaling
Xaralabos Varelas et al.
DEVELOPMENTAL CELL (2010)
Yes-associated protein (YAP) functions as a tumor suppressor in breast
M. Yuan et al.
CELL DEATH AND DIFFERENTIATION (2008)
Origin of androgen-insensitive poorly differentiated tumors in the Transgenic adenocarcinoma of mouse prostate model
Wendy J. Huss et al.
NEOPLASIA (2007)
Molecular regulation of androgen action in prostate cancer
Scott M. Dehm et al.
JOURNAL OF CELLULAR BIOCHEMISTRY (2006)
A human- and male-specific protocadherin that acts through the Wnt signaling pathway to induce neuroendocrine transdifferentiation of prostate cancer cells
XZ Yang et al.
CANCER RESEARCH (2005)
An allograft model of androgen independent prostatic neuroendocrine carcinoma derived from a large probasin promoter-T antigen transgenic mouse line
N Masumori et al.
JOURNAL OF UROLOGY (2004)
Zebrafish prickle, a modulator of noncanonical Wnt/Fz signaling, regulates gastrulation movements
MT Veeman et al.
CURRENT BIOLOGY (2003)
Share Paper
